Mr. Dahl is currently a private investor, focusing on the healthcare industry. Previously, he was the co-founder and Chief Operating Officer of Arrowhawk Capital Partners, an investment company and the Vice President of Strategic Business Development and Vice Chairman of the Board of Directors of Golden Pond Healthcare, Inc. From 1999 until 2006, Mr. Dahl served as the head of Global Healthcare for the Carlyle Group, a leading private equity firm, where he was responsible for the firm's investments in the healthcare field. Prior to Carlyle, Mr. Dahl served as co-head of healthcare investment banking in North America at Credit Suisse First Boston. Mr. Dahl is a director of several private companies. He is also a member of the Board of Trustees of the Cancer Research Institute and YMCA Camp Belknap. Mr. Dahl received a BA from Middlebury College and an MBA with high distinction from the Harvard Business School.
Mr. Epstein is a member of the Health Care and Life Sciences practice of Epstein Becker Green in the Washington, DC, and New York offices, where he advises clients on a broad range of regulatory, strategic, transactional, reimbursement, and industry-related matters. Mr. Epstein also actively works with a number of health care companies as a board member and advisor, including Fallon Health Weinberg (Director), Appian360 (Director), Inception Fertility Ventures (Director), Fitzroy Health Holdings (Director), Cognitive Clinical Trials (Director), and Radius Ventures (Venture Advisor).Mr. Epstein earned a doctorate in philosophy from New York University in 2011. Earlier, while at Harvard Law School, he received the Joseph Beale Conflicts of Law Prize, graduating with honors in 2008.
Tom is the CEO of USC Keck Medical System and current board member of the California Hospital Association. Prior to joining USC in 2012, he served as CEO of UCSD Health System. He holds a Master of Public Health in health policy and management from Columbia University and a bachelor’s degree in business administration from the University of Georgia.
Chuck has served as the CEO and President for numerous companies
in the healthcare and business information services industries . He has created seven platform companies; growing all through internal development and acquisition, averaging return to shareholders of five times invested capital. Prior to serving as a managing director and senior advisor to boutique investment bank Coady Diemar, Chuck was Chairman and CEO of Peminic (Verge Solutions), a provider of IT healthcare process management software. Prior to that he was CEO and Executive Chairman of Solucient (Truven Health Analytics), a $100 million market leader providing software solutions to Hospitals. Chuck was also President of the VNU marketing information group (Nielsen), growing revenue from $70 million to $400 million over a 10-year period. Chuck earned an MBA from Wharton, a BA from MIT and a AB from Middlebury College.
Steve has been an entrepreneur and board member of many companies and is now Senior Advisor to Triple Tree, a leading healthcare technology merchant bank and private equity firm. He sits on the boards of Imagescan (transactional content management), RXRevu (prescription clinical decision support and analytics) and Cleveland Clinic Innovations, and is a consultant to Partners Healthcare and Ariadne Labs.
Eric C. Rackow, M.D. heads Humana At Home and is responsible for the growth and continuing success of the division. Additionally, Dr. Rackow serves as a Professor of Medicine at the New York University School of Medicine. Prior to his current role, he was president and CEO of SeniorBridge, where under his leadership the company tripled in size to nearly 50 homecare offices and a nationwide network of more than 14,000 care managers coast to coast.
Michael D. Robinson is the former Vice President for Microsoft’s Health and Life Sciences business in the United States, where he was responsible for driving Microsoft’s multi-billion dollar business initiatives into both commercial and public sector organizations in the Provider, Payer, Life Sciences, Public Health and Human Services verticals. He is now the managing partner of investment firm Miro Ventures, and serves on the board of predictive analytics company NovoDynamics. Prior to joining Microsoft, he held leadership positions at Hitachi Data Systems, Sterling Software and Robinson-Cole/Trecom Business Systems. Michael holds a bachelor of science in Management from National-Louis University in Chicago and an executive MBA from Pace University.
Egbert is the CEO of Qatar Foundation’s World Innovation Summit for Health. He is a seasoned business leader with 20 years' experience in the global healthcare industry, across payers, provider systems, best practice research, and consulting. Previously, he was SVP of Client Service for McKinsey’s Leading Systems Network, which convened health systems globally for collective performance improvement. Prior to joining McKinsey, Mr. Schillings served as Managing Director at Kaiser Permanente.
Martin is an IBM Fellow, Institute of Medicine Member and Vice President of Health Systems and Policy Research, Research Division, IBM Corporation. He previously served as IBM VP Integrated Health Services and led health policy and strategy, health benefits innovation and purchasing, occupational health and well-being services for IBM globally, where he delivered cost avoidance in excess of $1.7B. He is a former board member of the Population Health and Public Policy Practice and current board member of the American Board of Internal Medicine.
Tom is a current Director and former CEO of Summa Health, one of the largest integrated delivery networks in Ohio. In addition to leading the 2000 bed health system, Tom also is renowned for spearheading practical approaches to innovative delivery models and value-based care. In addition to advising Fitzroy Health, he is also leading our efforts to convene networks of industry leaders to promote and accelerate health care innovation.l.
Ashley advises Fitzroy’s fast-growing ventures on how to scale smartly. With a background in finance, technology and healthcare, Ashley brings with her over a decade of experience working with emerging entrepreneurs to get their product to market. She works with portfolio companies to map out growth strategy for human capital and operations, as well as assists with execution. Ashley believes that in addition to having a viable product, the real difference between success and failure of a company hinges directly on the people who comprise the organization.